Skip to main content
. 2022 Mar 17;36(4):e24337. doi: 10.1002/jcla.24337

FIGURE 2.

FIGURE 2

Upregulation of hsa_circ_0079480 in acute myeloid leukemia (AML) patient serum is related to worse survival outcomes. AML patients with higher levels of serum hsa_circ_0079480 exhibited worse overall survival (OS) (A) and relapse‐free survival (RFS) (B) as compared to patients with lower serum levels of hsa_circ_0079480